These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 9153548

  • 21. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
    Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Gulati S, Handa R.
    Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
    [Abstract] [Full Text] [Related]

  • 22. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
    De Paepe B, Schröder JM, Martin JJ, Racz GZ, De Bleecker JL.
    Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 25. Immunolocalization of protein-bound 3-nitrotyrosine in inflammatory myopathies.
    Zámecník J, Vytásek R, Vencovský J, Vilím V.
    Cesk Patol; 2011 Apr 01; 47(2):62-5. PubMed ID: 21598762
    [Abstract] [Full Text] [Related]

  • 26. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.
    Nyberg P, Wikman AL, Nennesmo I, Lundberg I.
    J Rheumatol; 2000 Apr 01; 27(4):940-8. PubMed ID: 10782820
    [Abstract] [Full Text] [Related]

  • 27. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.
    Englund P, Nennesmo I, Klareskog L, Lundberg IE.
    Arthritis Rheum; 2002 Apr 01; 46(4):1044-55. PubMed ID: 11953983
    [Abstract] [Full Text] [Related]

  • 28. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
    De Bleecker JL, Meire VI, Van Walleghem IE, Groessens IM, Schröder JM.
    Acta Neuropathol; 2001 Jun 01; 101(6):572-8. PubMed ID: 11515785
    [Abstract] [Full Text] [Related]

  • 29. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K, Dalakas MC.
    Am J Pathol; 1999 Aug 01; 155(2):453-60. PubMed ID: 10433938
    [Abstract] [Full Text] [Related]

  • 30. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A, Daniels BH, Margeta M.
    J Neuropathol Exp Neurol; 2016 Mar 01; 75(3):239-45. PubMed ID: 26843609
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D.
    Presse Med; 2009 Mar 01; 38(7-8):1141-63. PubMed ID: 19282137
    [Abstract] [Full Text] [Related]

  • 33. Inflammatory and toxic myopathies.
    Dalakas MC.
    Curr Opin Neurol Neurosurg; 1992 Oct 01; 5(5):645-54. PubMed ID: 1327303
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
    Gabay C, Gay-Croisier F, Roux-Lombard P, Meyer O, Maineti C, Guerne PA, Vischer T, Dayer JM.
    Arthritis Rheum; 1994 Dec 01; 37(12):1744-51. PubMed ID: 7986220
    [Abstract] [Full Text] [Related]

  • 36. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.
    Ann Rheum Dis; 2007 Oct 01; 66(10):1276-83. PubMed ID: 17277004
    [Abstract] [Full Text] [Related]

  • 37. Concomitant in vivo production of 19 different cytokines in human tonsils.
    Andersson J, Abrams J, Björk L, Funa K, Litton M, Agren K, Andersson U.
    Immunology; 1994 Sep 01; 83(1):16-24. PubMed ID: 7821961
    [Abstract] [Full Text] [Related]

  • 38. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
    Sugiura T, Kawaguchi Y, Harigai M, Takagi K, Ohta S, Fukasawa C, Hara M, Kamatani N.
    J Immunol; 2000 Jun 15; 164(12):6593-600. PubMed ID: 10843719
    [Abstract] [Full Text] [Related]

  • 39. Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.
    Yin X, Han GC, Jiang XW, Shi Q, Pu CQ.
    Chin Med J (Engl); 2016 May 05; 129(9):1047-52. PubMed ID: 27098789
    [Abstract] [Full Text] [Related]

  • 40. Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
    Liu T, Hou Y, Dai TJ, Yan CZ.
    Chin Med J (Engl); 2017 Sep 05; 130(17):2101-2106. PubMed ID: 28836555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.